United Kingdom

Latest Headlines

Latest Headlines

U.K. starts work on $64M biologics manufacturing center

The U.K. is investing £38 million in its National Biologics Manufacturing Centre, part of the country's "High Value Manufacturing Catapult" effort started several years ago to increase its presence in biologics.

Party drug turned 'miracle' cure for depression spurs hype and stubborn hope

The notion that a party drug could be repurposed into a "miracle" cure for severe, treatment-resistant depression is an almost irresistible story line in the popular press. And there's no reason why it can't be recycled using results from the same small, short-duration study design that long ago attracted some of the world's largest research organizations still engaged in researching new drugs in one of the most difficult fields in R&D.

Is Europe due for a biotech boom all its own?

With London biotech Circassia clearing about $332 million in a record-breaking U.K. IPO, a spate of other European life sciences outfits sit stage left with eyes on the public markets, stoking hopes that the stateside fervor over drug developers could cross the ocean and line their pockets.

U.K. mulls adopting a 2-dose model for HPV vaccination

If the U.K. adopts the two-shot model, it may use the cash it saves to vaccinate boys against HPV.

GSK shares grant to help U.K. on how to rebuild its drug manufacturing base

GlaxoSmithKline, which is making big investments in manufacturing in the U.K., will help its homeland try to figure out how to revive its manufacturing base.

Report: U.K. facing $100M compensation payout relating to GSK's swine flu vaccine

While Finland agreed to pay out in 2011, the U.K. was still knocking back claimants in 2012. Now, though, the U.K. government is reportedly readying to pay 60 people $1.7 million each.

U.K. begins trying to rebuild trust in patient database after months of 'confusion, suspicion and anxiety'

The United Kingdom's long history of public healthcare gives it an enviable trove of patient data. Yet this resource, which is perhaps the one true competitive edge possessed by U.K. biopharma, is at risk of being squandered as the project continues to buried by mismanagement and a blizzard of negative publicity.

Another life sciences IPO pitch in U.K. raises hopes for upturn

Horizon Discovery Group, which makes and sells tools for genomics research and personalized medicines, has set out to raise about $41.5 million on the AIM market on the London Stock Exchange.

GSK vows to maintain soccer fields in new U.K. plant

GlaxoSmithKline is investing £350 million in a new plant in Ulverston, U.K., that will generate 500 new jobs, increase drug capacity and potentially draw on wind power to lower its environmental impact. But what about the football fields?

Biogen Idec hits its first price hurdle for Tecfidera in the EU

Biogen Idec's hot-selling multiple sclerosis drug Tecfidera has to win reimbursement in individual European countries where governments have gotten stingy about parting with healthcare dollars. A decision Thursday by U.K. price watchdog NICE is an indication of the cost hurdles to be faced.